학술논문

MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS
Document Type
Article
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S303-S304
Subject
Language
ISSN
2152-2650